To include your compound in the COVID-19 Resource Center, submit it here.

TroVax: Phase II started

Oxford BioMedica said the Velindre Cancer Centre began the open-label, U.K. Phase II SKOPOS trial

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE